Savannah McKay, 28, was a high-flying model from Melbourne on her way to stardom but instead ended up homeless and behind ...

Experimental drug NU-9 -- a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) -- improves ...

Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials ...

A new report published in Brain Medicine reveals that a single dose of the drug Osanetant, administered shortly after a ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

A dangerous veterinary sedative called xylazine has been found in the drug supply at the U.S.-Mexico border, raising alarms ...

ATH434 is a Disease Modifying Drug Candidate Targeting Parkinsonian Disorders –– Topline Data Expected Mid-Year 2025 –MELBOURNE, Australia and ...

Experts from across the toxicology field highlighted the latest research and testing methods shaping the future of the industry, at the Society of Toxicology (SOT) 2025 annual meeting, in Orlando, ...

In his "raw" and "unflinching" book Spare, the Duke spoke in depth about his previous drug use - and it's led to questions about his US visa and whether he received 'special treatment'.

Today, he’s in remission. The lifesaving drug regimen wasn’t thought up by the doctor, or any person. It had been spit out by an artificial intelligence model. In labs around the world ...

Currently, antibody candidates are analyzed individually in animal models. A large number of laboratory animals are normally used to conduct each test. This is why preclinical ... that are already ...

Google also unveiled new open AI models for drug discovery called TxGemma, following the company’s launch of a collection of Gemini AI models for multimodal use cases in healthcare. TxGemma is ...